🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and effectiveness of ...
Status
Completed
Location
Swedish American Neuro and Headache Center
Start Date
2014-08
Trial ID
NCT02176018
Treatments Being Tested
To compare pharmacokinetics (PK) of AVP-786 (deuterated \[d6\] dextromethor...
Status
Completed
Location
Covance Dallas Clinical Research Unit
Start Date
2014-05-01
Trial ID
NCT02336347
Objectives of the study are to evaluate the safety, tolerability, and effic...
Status
Completed
Location
St. Joseph's Hospital and Medical Center
Start Date
2007-12
Trial ID
NCT00573443
The purpose of this study is to determine the effects of a potent CYP3A4 in...
Status
Completed
Location
Vince and Associates Clinical Research, Inc.
Start Date
2015-03-01
Trial ID
NCT02402595
Treatments Being Tested
Nuedexta is FDA approved for the treatment of pseudobulbar affect in ALS pa...
Status
Completed
Location
Phil Smith Neuroscience Institute at Holy Cross Hospital
Start Date
2019-07-25
Trial ID
NCT03883581
Treatments Being Tested
The purpose of this study is to determine whether dextromethorphan (Neurode...
Status
Completed
Location
Pivotal Research Centers
Start Date
2005-07
Trial ID
NCT00113620
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety of AVP-923 in...
Status
Completed
Location
Barrow Neurological Institute
Start Date
2003-02
Trial ID
NCT00056524
Treatments Being Tested
Phenotyping is an approach largely used for the evaluation of the activity ...
Status
Completed
Location
University Hospitals
Start Date
2012-11
Trial ID
NCT01731067
Treatments Being Tested
The objectives of the study are to evaluate the safety, tolerability and ef...
Status
Completed
Location
Multiple Locations
Start Date
2012-08-13
Trial ID
NCT01584440
Treatments Being Tested
The objectives of the study are to evaluate the safety, tolerability, and e...
Status
Completed
Location
Multiple Locations
Start Date
2013-02
Trial ID
NCT01799941
Treatments Being Tested